Skip to main content
Erschienen in: World Journal of Urology 6/2016

29.09.2015 | Original Article

Extended versus limited pelvic lymph node dissection during bilateral nerve-sparing radical prostatectomy and its effect on continence and erectile function recovery: long-term results and trifecta rates of a comparative analysis

verfasst von: Georgios Hatzichristodoulou, Stefan Wagenpfeil, Gudrun Wagenpfeil, Tobias Maurer, Thomas Horn, Kathleen Herkommer, Marie Hegemann, Jürgen E. Gschwend, Hubert Kübler

Erschienen in: World Journal of Urology | Ausgabe 6/2016

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To assess continence and erectile function (EF) recovery of extended pelvic lymph node dissection (ePLND) versus limited PLND (lPLND) after bilateral nerve-sparing radical prostatectomy (BNSRP).

Methods

Consecutive prostate cancer (PCa) patients undergoing BNSRP were stratified according to D’Amico into two groups: low-risk-PCa lPLND (obturator) and intermediate-/high-risk-PCa ePLND (obturator, external iliac artery, internal iliac artery, common iliac artery). Continence (no pad/one safety pad) and EF (IIEF-5 ≥ 17) recovery were assessed. Patients with phosphodiesterase type 5 inhibitors, neoadjuvant/adjuvant therapy, positive lymph nodes or positive surgical margins were excluded.

Results

From January 2007 to May 2012, a total 966 consecutive patients were included. Four hundred and sixty patients met the inclusion/exclusion criteria: 262 patients had ePLND and 198 patients had lPLND. Mean number of lymph nodes was 20.4 (range 10–65) and 4.7 (range 0–10), respectively (p < 0.001). Continence and spontaneous EF recovery after 12 months were 89.7 versus 93.4 % and 40.4 versus 47.5 %, respectively (all p > 0.05). Patient age at surgery (p = 0.001), preoperative EF (p < 0.001) and pathological tumor stage (p = 0.008), but not ePLND (p = 0.561), were independent predictors of EF recovery. No association was detected for continence recovery. Seven-year BCR-free survival for pT2 PCa was 100 and 94.8 % in lPLND and ePLND, respectively (p = 0.011). For pT3 PCa, this was 94.7 and 81.2 %, respectively (p = 0.287). At 2 years, the trifecta of continence, potency and recurrence freedom was achieved in 47.5 and 44.1 % in lPLND and ePLND, respectively (p = 0.451).

Conclusions

ePLND is not associated with increased risk of postoperative incontinence or erectile dysfunction. Only patient age at surgery, preoperative EF and pathological tumor stage represent predictors of EF recovery.
Literatur
1.
Zurück zum Zitat Khoder W, Waidelich R, Seitz M et al (2015) Do we need the nerve sparing radical prostatectomy techniques (intrafascial vs. interfascial) in men with erectile dysfunction? Results of a single-centre study. World J Urol 33:301–307CrossRefPubMed Khoder W, Waidelich R, Seitz M et al (2015) Do we need the nerve sparing radical prostatectomy techniques (intrafascial vs. interfascial) in men with erectile dysfunction? Results of a single-centre study. World J Urol 33:301–307CrossRefPubMed
2.
Zurück zum Zitat Xylinas E, Ploussard G, Durand X et al (2010) Evaluation of combined oncological and functional outcomes after radical prostatectomy: trifecta rate of achieving continence, potency and cancer control—a literature review. Urology 76:1194–1198CrossRefPubMed Xylinas E, Ploussard G, Durand X et al (2010) Evaluation of combined oncological and functional outcomes after radical prostatectomy: trifecta rate of achieving continence, potency and cancer control—a literature review. Urology 76:1194–1198CrossRefPubMed
3.
Zurück zum Zitat Tasci A, Tufek I, Gumus E et al (2014) Oncologic results, functional outcomes, and complication rates of robotic-assisted radical prostatectomy: multicenter experience in Turkey including 1,499 patients. World J Urol. doi:10.1007/s00345-014-1393-3 PubMed Tasci A, Tufek I, Gumus E et al (2014) Oncologic results, functional outcomes, and complication rates of robotic-assisted radical prostatectomy: multicenter experience in Turkey including 1,499 patients. World J Urol. doi:10.​1007/​s00345-014-1393-3 PubMed
4.
Zurück zum Zitat D’Amico A, Whittington R, Malkowicz SB et al (1998) Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer. JAMA 280:969–974CrossRefPubMed D’Amico A, Whittington R, Malkowicz SB et al (1998) Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer. JAMA 280:969–974CrossRefPubMed
5.
Zurück zum Zitat Heidenreich A, Bastian PJ, Bellmunt J et al (2014) EAU Guidelines on prostate cancer. Part 1: screening, diagnosis, and local treatment with curative intent—update 2013. Eur Urol 65:124–137CrossRefPubMed Heidenreich A, Bastian PJ, Bellmunt J et al (2014) EAU Guidelines on prostate cancer. Part 1: screening, diagnosis, and local treatment with curative intent—update 2013. Eur Urol 65:124–137CrossRefPubMed
6.
Zurück zum Zitat Gandaglia G, Suardi N, Gallina A et al (2012) Extended pelvic lymph node dissection does not affect erectile function recovery in patients treated with bilateral nerve-sparing radical prostatectomy. J Sex Med 9:2187–2194CrossRefPubMed Gandaglia G, Suardi N, Gallina A et al (2012) Extended pelvic lymph node dissection does not affect erectile function recovery in patients treated with bilateral nerve-sparing radical prostatectomy. J Sex Med 9:2187–2194CrossRefPubMed
7.
Zurück zum Zitat Ledezma R, Negron E, Razmaria AA et al (2015) Robotic-assisted pelvic lymph node dissection for prostate cancer: frequency of nodal metastases and oncological outcomes. World J Urol. doi:10.1007/s00345-015-1515-6 Ledezma R, Negron E, Razmaria AA et al (2015) Robotic-assisted pelvic lymph node dissection for prostate cancer: frequency of nodal metastases and oncological outcomes. World J Urol. doi:10.​1007/​s00345-015-1515-6
8.
Zurück zum Zitat Bivalacqua T, Pierorazio PM, Gorin MA et al (2013) Anatomic extent of pelvic lymph node dissection: impact on long-term cancer-specific outcomes in men with positive lymph nodes at time of radical prostatectomy. Urology 82:653–659CrossRefPubMedPubMedCentral Bivalacqua T, Pierorazio PM, Gorin MA et al (2013) Anatomic extent of pelvic lymph node dissection: impact on long-term cancer-specific outcomes in men with positive lymph nodes at time of radical prostatectomy. Urology 82:653–659CrossRefPubMedPubMedCentral
9.
Zurück zum Zitat Passoni N, Abdollah F, Suardi N et al (2014) Head-to-head comparison of lymph node density and number of positive lymph nodes in stratifying the outcome of patients with lymph node-positive prostate cancer submitted to radical prostatectomy and extended lymph node dissection. Urol Oncol 32:21–28 Passoni N, Abdollah F, Suardi N et al (2014) Head-to-head comparison of lymph node density and number of positive lymph nodes in stratifying the outcome of patients with lymph node-positive prostate cancer submitted to radical prostatectomy and extended lymph node dissection. Urol Oncol 32:21–28
10.
Zurück zum Zitat Ficarra V, Novara G, Ahlering TE et al (2012) Systematic review and meta-analysis of studies reporting potency rates after robot-assisted radical prostatectomy. Eur Urol 62:418–430CrossRefPubMed Ficarra V, Novara G, Ahlering TE et al (2012) Systematic review and meta-analysis of studies reporting potency rates after robot-assisted radical prostatectomy. Eur Urol 62:418–430CrossRefPubMed
11.
Zurück zum Zitat Sagalovich D, Calaway A, Srivastava A, Sooriakumaran P, Tewari AK (2012) Assessment of required nodal yield in a high risk cohort undergoing extended pelvic lymphadenectomy in robotic-assisted radical prostatectomy and its impact on functional outcomes. BJU Int 111:85–94CrossRefPubMed Sagalovich D, Calaway A, Srivastava A, Sooriakumaran P, Tewari AK (2012) Assessment of required nodal yield in a high risk cohort undergoing extended pelvic lymphadenectomy in robotic-assisted radical prostatectomy and its impact on functional outcomes. BJU Int 111:85–94CrossRefPubMed
12.
Zurück zum Zitat Pettenati C, Neuzillet Y, Radulescu C, Hervé JM, Molinié V, Lebret T (2015) Positive surgical margins after radical prostatectomy: What should we care about? World J Urol. doi:10.1007/s00345-015-1580-x PubMed Pettenati C, Neuzillet Y, Radulescu C, Hervé JM, Molinié V, Lebret T (2015) Positive surgical margins after radical prostatectomy: What should we care about? World J Urol. doi:10.​1007/​s00345-015-1580-x PubMed
13.
Zurück zum Zitat Michl U, Molfenter F, Graefen M et al (2015) Use of PDE5-inhibitors may adversely impact biochemical recurrence following radical prostatectomy. J Urol 193:479–483CrossRefPubMed Michl U, Molfenter F, Graefen M et al (2015) Use of PDE5-inhibitors may adversely impact biochemical recurrence following radical prostatectomy. J Urol 193:479–483CrossRefPubMed
14.
Zurück zum Zitat Mattei A, Battista di Piero G, Grande P, Beutler J, Danuser H et al (2013) Standardized and simplified extended pelvic lymph node dissection during robot-assisted radical prostatectomy: the Monoblock technique. Urology 81:446–450CrossRefPubMed Mattei A, Battista di Piero G, Grande P, Beutler J, Danuser H et al (2013) Standardized and simplified extended pelvic lymph node dissection during robot-assisted radical prostatectomy: the Monoblock technique. Urology 81:446–450CrossRefPubMed
15.
Zurück zum Zitat Ludwig W, Tewari A (2013) Retraction of external iliac vessels and obturator nerve with the vas deferens during extended pelvic lymph node dissection in robot-assisted radical prostatectomy. Urology 81:1369–1371CrossRefPubMed Ludwig W, Tewari A (2013) Retraction of external iliac vessels and obturator nerve with the vas deferens during extended pelvic lymph node dissection in robot-assisted radical prostatectomy. Urology 81:1369–1371CrossRefPubMed
16.
Zurück zum Zitat Park J, Yoo DS, Song C, Park S, Park S, Kim SC, Cho Y, Ahn H et al (2014) Comparison of oncological outcomes between retropubic radical prostatectomy and robot-assisted radical prostatectomy: an analysis stratified by surgical experience. World J Urol 32:193–199CrossRefPubMed Park J, Yoo DS, Song C, Park S, Park S, Kim SC, Cho Y, Ahn H et al (2014) Comparison of oncological outcomes between retropubic radical prostatectomy and robot-assisted radical prostatectomy: an analysis stratified by surgical experience. World J Urol 32:193–199CrossRefPubMed
17.
Zurück zum Zitat Karl A, Buchner A, Tympner C et al (2015) The natural course of pT2 prostate cancer with positive surgical margin: predicting biochemical recurrence. World J Urol. doi:10.1007/s00345-015-1510-y Karl A, Buchner A, Tympner C et al (2015) The natural course of pT2 prostate cancer with positive surgical margin: predicting biochemical recurrence. World J Urol. doi:10.​1007/​s00345-015-1510-y
18.
Zurück zum Zitat Pokala N, Trulson JJ, Islam M (2014) Long-term outcome following radical prostatectomy for Gleason 8–10 prostatic adenocarcinoma. World J Urol 32:1385–1392CrossRefPubMed Pokala N, Trulson JJ, Islam M (2014) Long-term outcome following radical prostatectomy for Gleason 8–10 prostatic adenocarcinoma. World J Urol 32:1385–1392CrossRefPubMed
19.
Zurück zum Zitat Billia M, Elhage O, Challacombe B et al (2014) Oncological outcomes of robotic-assisted radical prostatectomy after more than 5 years. World J Urol 32:413–418CrossRefPubMed Billia M, Elhage O, Challacombe B et al (2014) Oncological outcomes of robotic-assisted radical prostatectomy after more than 5 years. World J Urol 32:413–418CrossRefPubMed
20.
Zurück zum Zitat Novara G, Ficarra V, D’Elia C, Secco S, Cavalleri S, Artibani W (2010) Trifecta outcomes after robot-assisted radical prostatectomy. BJU Int 107:100–104CrossRef Novara G, Ficarra V, D’Elia C, Secco S, Cavalleri S, Artibani W (2010) Trifecta outcomes after robot-assisted radical prostatectomy. BJU Int 107:100–104CrossRef
21.
Zurück zum Zitat Lavery H, Nabizada-Pace F, Carlussi JR, Brajtbord JS, Samadi DB (2012) Nerve-sparing robotic prostatectomy in preoperatively high-risk patients is safe and efficacious. Urol Oncol 30:26–32CrossRefPubMed Lavery H, Nabizada-Pace F, Carlussi JR, Brajtbord JS, Samadi DB (2012) Nerve-sparing robotic prostatectomy in preoperatively high-risk patients is safe and efficacious. Urol Oncol 30:26–32CrossRefPubMed
22.
Zurück zum Zitat Briganti A, Capitanio U, Chun FK, Karakiewicz PI, Salonia A, Bianchi M, Cestari A, Guazzoni G, Rigatti P, Montorsi F et al (2009) Prediction of sexual function after radical prostatectomy. Cancer 115:150–159CrossRef Briganti A, Capitanio U, Chun FK, Karakiewicz PI, Salonia A, Bianchi M, Cestari A, Guazzoni G, Rigatti P, Montorsi F et al (2009) Prediction of sexual function after radical prostatectomy. Cancer 115:150–159CrossRef
23.
Zurück zum Zitat Tewari A, Sooriakumaran P, Bloch DA, Seshadri-Kreaden U, Hebert AE, Wiklund P et al (2012) Positive surgical margin and perioperative complications rates of primary surgical treatments for prostate cancer: a systematic review and meta-analysis comparing retropubic, laparoscopic, and robotic prostatectomy. Eur Urol 62:1–15CrossRefPubMed Tewari A, Sooriakumaran P, Bloch DA, Seshadri-Kreaden U, Hebert AE, Wiklund P et al (2012) Positive surgical margin and perioperative complications rates of primary surgical treatments for prostate cancer: a systematic review and meta-analysis comparing retropubic, laparoscopic, and robotic prostatectomy. Eur Urol 62:1–15CrossRefPubMed
24.
Zurück zum Zitat Nitti V, Mourtzinos A, Brucker BM, SUFU Pad Test Study Group (2014) Correlation of patient perception of pad use with objective degree of incontinence measured by pad test in men with post-prostatectomy incontinence: the SUFU Pad Test Study. J Urol 192:836–842CrossRefPubMed Nitti V, Mourtzinos A, Brucker BM, SUFU Pad Test Study Group (2014) Correlation of patient perception of pad use with objective degree of incontinence measured by pad test in men with post-prostatectomy incontinence: the SUFU Pad Test Study. J Urol 192:836–842CrossRefPubMed
25.
Zurück zum Zitat Suardi N, Moschini M, Gallina A et al (2012) Nerve-sparing approach during radical prostatectomy is strongly associated with the rate of postoperative urinary continence recovery. BJU Int 111:717–722CrossRefPubMed Suardi N, Moschini M, Gallina A et al (2012) Nerve-sparing approach during radical prostatectomy is strongly associated with the rate of postoperative urinary continence recovery. BJU Int 111:717–722CrossRefPubMed
26.
Zurück zum Zitat Jeong S, Yeon JS, Lee JK et al (2014) Development and validation of nomograms to predict the recovery of urinary continence after radical prostatectomy: comparisons between immediate, early, and late continence. World J Urol 32:437–444CrossRefPubMed Jeong S, Yeon JS, Lee JK et al (2014) Development and validation of nomograms to predict the recovery of urinary continence after radical prostatectomy: comparisons between immediate, early, and late continence. World J Urol 32:437–444CrossRefPubMed
Metadaten
Titel
Extended versus limited pelvic lymph node dissection during bilateral nerve-sparing radical prostatectomy and its effect on continence and erectile function recovery: long-term results and trifecta rates of a comparative analysis
verfasst von
Georgios Hatzichristodoulou
Stefan Wagenpfeil
Gudrun Wagenpfeil
Tobias Maurer
Thomas Horn
Kathleen Herkommer
Marie Hegemann
Jürgen E. Gschwend
Hubert Kübler
Publikationsdatum
29.09.2015
Verlag
Springer Berlin Heidelberg
Erschienen in
World Journal of Urology / Ausgabe 6/2016
Print ISSN: 0724-4983
Elektronische ISSN: 1433-8726
DOI
https://doi.org/10.1007/s00345-015-1699-9

Weitere Artikel der Ausgabe 6/2016

World Journal of Urology 6/2016 Zur Ausgabe

Update Urologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.